Recurrent somatic mutations in the Src homology 2 (SH2) domain of the signal transducer and activator of transcription 3 (STAT3) gene have been found in 27-40% of patients with T-LGL leukemia and 30% of patients with CLPD-NK. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.